"Designing Growth Strategies is in our DNA"

Antiviral Drugs Market Size, Share & Industry Analysis, By Drug Class (Protease Inhibitors, Polymerase Inhibitors, Integrase Inhibitors, Combination Drugs, Reverse Transcriptase Inhibitors, and Others), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel) and Regional Forecast, 2025-2032

Last Updated: June 26, 2025 | Format: PDF | Report ID: FBI102190

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Key Industry Trends
    2. Recent industry developments such as mergers & acquisitions
    3. regulatory and reimbursement scenario for key countries
    4. Prevalence of Key viral diseases, in major countries, 2024
    5. New Product Launches
  5. Global Antiviral Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis, Insights and Forecast – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Antiviral Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Antiviral Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Antiviral Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Antiviral Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Antiviral Drugs Market Analysis, Insights and Forecast, 2019-2032
    1. Key Findings / Summary
    2. Market Analysis – By Disease Indication
      1. Hepatitis
      2. Human Immunodeficiency Virus (HIV)
      3. Influenza
      4. Others
    3. Market Analysis – By Drug Class
      1. Integrase Inhibitors
      2. Polymerase Inhibitors
      3. Protease Inhibitors
      4. Combination Drugs
      5. Reverse Transcriptase Inhibitors
      6. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
    5. Market Analysis – By Country/Sub-region
      1. GCC Countries
      2. South Africa
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2018)
    3. Competition Dashboard
    4. Comparative Analysis – Major Players
    5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Gilead Sciences
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. GlaxoSmithKline
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Abbvie, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Merck & Co., Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Bristol-Myers Squibb Company
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Janssen Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Mylan N.V.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Antiviral Drugs Market Revenue Breakdown (US$ Mn, %) by Region, 2024 & 2032

Figure 2:  Global Antiviral Drugs Market Value Share (%), by Drug Class, 2024 & 2032

Figure 3:  Global Antiviral Drugs Market Forecast (US$ Mn), by Integrase Inhibitors, 2019-2032

Figure 4:  Global Antiviral Drugs Market Forecast (US$ Mn), by Polymerase Inhibitors, 2019-2032

Figure 5:  Global Antiviral Drugs Market Forecast (US$ Mn), by Protease Inhibitors, 2019-2032

Figure 6:  Global Antiviral Drugs Market Forecast (US$ Mn), by Combination Drugs, 2019-2032

Figure 7:  Global Antiviral Drugs Market Forecast (US$ Mn), by Reverse Transcriptase Inhibitors, 2019-2032

Figure 8:  Global Antiviral Drugs Market Forecast (US$ Mn), by Others, 2019-2032

Figure 9:  Global Antiviral Drugs Market Value Share (%), by Disease Indication, 2024 & 2032

Figure 10:  Global Antiviral Drugs Market Forecast (US$ Mn), by Hepatitis, 2019-2032

Figure 11:  Global Antiviral Drugs Market Forecast (US$ Mn), by Human Immunodeficiency Virus (HIV), 2019-2032

Figure 12:  Global Antiviral Drugs Market Forecast (US$ Mn), by Influenza, 2019-2032

Figure 13:  Global Antiviral Drugs Market Value Share (%), by Distribution Channel, 2024 & 2032

Figure 14:  Global Antiviral Drugs Market Forecast (US$ Mn), by Hospital Pharmacy, 2019-2032

Figure 15:  Global Antiviral Drugs Market Forecast (US$ Mn), by Retail Pharmacy, 2019-2032

Figure 16:  Global Antiviral Drugs Market Forecast (US$ Mn), by Online Channel, 2019-2032

Figure 17:  Global Antiviral Drugs Market Value (US$ Mn), by Region, 2024 & 2032

Figure 18:  North America Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2024 & 2032

Figure 19:  North America Antiviral Drugs Market Value Share (%), by Drug Class, 2024

Figure 20:  North America Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2024 & 2032

Figure 21:  North America Antiviral Drugs Market Value Share (%), by Disease Indication, 2024

Figure 22:  North America Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 23:  North America Antiviral Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 24:  North America Antiviral Drugs Market Value (US$ Mn), By Country, 2024 & 2032

Figure 25:  North America Antiviral Drugs Market Value Share (%), By Country, 2024

Figure 26:  Europe Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2024 & 2032

Figure 27:  Europe Antiviral Drugs Market Value Share (%), by Drug Class, 2024

Figure 28:  Europe Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2024 & 2032

Figure 29:  Europe Antiviral Drugs Market Value Share (%), by Disease Indication, 2024

Figure 30:  Europe Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 31:  Europe Antiviral Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 32:  Europe Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 33:  Europe Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2024

Figure 34:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2024 & 2032

Figure 35:  Asia Pacific Antiviral Drugs Market Value Share (%), by Drug Class, 2024

Figure 36:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2024 & 2032

Figure 37:  Asia Pacific Antiviral Drugs Market Value Share (%), by Disease Indication, 2024

Figure 38:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 39:  Asia Pacific Antiviral Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 40:  Asia Pacific Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 41:  Asia Pacific Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2024

Figure 42:  Latin America Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2024 & 2032

Figure 43:  Latin America Antiviral Drugs Market Value Share (%), by Drug Class, 2024

Figure 44:  Latin America Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2024 & 2032

Figure 45:  Latin America Antiviral Drugs Market Value Share (%), by Disease Indication, 2024

Figure 46:  Latin America Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 47:  Latin America Antiviral Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 48:  Latin America Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 49:  Latin America Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2024

Figure 50:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), by Drug Class, 2024 & 2032

Figure 51:  Middle East & Africa Antiviral Drugs Market Value Share (%), by Drug Class, 2024

Figure 52:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), by Disease Indication, 2024 & 2032

Figure 53:  Middle East & Africa Antiviral Drugs Market Value Share (%), by Disease Indication, 2024

Figure 54:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), by Distribution Channel, 2024 & 2032

Figure 55:  Middle East & Africa Antiviral Drugs Market Value Share (%), by Distribution Channel, 2024

Figure 56:  Middle East & Africa Antiviral Drugs Market Value (US$ Mn), By Country/ Sub-region, 2024 & 2032

Figure 57:  Middle East & Africa Antiviral Drugs Market Value Share (%), By Country/ Sub-region, 2024

Figure 58:  Global Antiviral Drugs Market Share (%), By Company, 2024

Table 1:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2015–2032

Table 2:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2015–2032

Table 3:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2032

Table 4:  Global Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Region, 2019-2032

Table 5:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2019-2032

Table 6:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2019-2032

Table 7:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 8:  North America Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country, 2019-2032

Table 9:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2019-2032

Table 10:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2019-2032

Table 11:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 12:  Europe Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 13:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2019-2032

Table 14:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2019-2032

Table 15:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 16:  Asia Pacific Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 17:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2019-2032

Table 18:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2019-2032

Table 19:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 20:  Latin America Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Table 21:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Drug Class, 2019-2032

Table 22:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Disease Indication, 2019-2032

Table 23:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2019-2032

Table 24:  Middle East & Africa Antiviral Drugs Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2019-2032

Antiviral Drugs Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2024
  • 2019-2023
  • 130
GET A FREE SAMPLE

    man icon
    Mail icon
    Captcha refresh
Consulting Services
    How will you benefit from our consulting services ?